Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-03-15, Stock:NVO, The news for the past five days is as follows:
2018-03-08: NEWS1: Novo Nordisk Focuses on Expanding Semaglutide’s Label.NEWS2: Novo Nordisk Focuses on Expanding Semaglutide’s Label.NEWS3: Label Expansion May Boost Xultophy’s Sales in 2018.NEWS4: Label Expansion May Boost Xultophy’s Sales in 2018.NEWS5: Saxenda May Continue to Lead in the Diabetes Segment in 2018.NEWS6: Saxenda May Continue to Lead in the Diabetes Segment in 2018.NEWS7: Xultophy May Prove a Strong Growth Driver for NVO in 2018.NEWS8: Xultophy May Prove a Strong Growth Driver for NVO in 2018.NEWS9: Novo Nordisk Has Developed a Portfolio of New-Generation Insulins.NEWS10: Novo Nordisk Has Developed a Portfolio of New-Generation Insulins.
2018-03-09: NEWS1: How AstraZeneca’s Revenues Trended in 4Q17.NEWS2: How AstraZeneca’s Revenues Trended in 4Q17.NEWS3: Vanguard FTSE Europe ETF Experiences Big Outflow.NEWS4: Vanguard FTSE Europe ETF Experiences Big Outflow.
2018-03-12: nan
2018-03-13: NEWS1: How AstraZeneca’s Other Products Portfolio Performed in 4Q17.NEWS2: How AstraZeneca’s Other Products Portfolio Performed in 4Q17.
2018-03-14: NEWS1: Orexigen Plummets on Filing of Chapter 11 of Bankruptcy Code.NEWS2: Orexigen Plummets on Filing of Chapter 11 of Bankruptcy Code.NEWS3: Novartis’s Innovative Medicines Business in 4Q17.NEWS4: Novartis’s Innovative Medicines Business in 4Q17.NEWS5: How Novartis’s Business Segments Performed in 4Q17.NEWS6: How Novartis’s Business Segments Performed in 4Q17.

Answer: Rise